InVitria
Slide 3

View Our New Posters Co-Authored with Pall Biotech

We’re excited to have partnered with Pall Biotech to publish two new posters.
- The first looks at leveraging biomass probes with chemically defined, serum-free media to optimize transfection cell density.
- The second demonstrates the optimization of the chemically defined media to be used for lentivirus production at scale with HEK293t cells.

Click to View and Download
Slide 2
Featured Review

Recent Advances of Chemical Definition of Cell Culture Media and Excipients for Virus and Viral Vector Manufacturing

Virus production is a critical step in cell and gene therapies and vaccine manufacture. Due to supply chain constraints, poor reproducibility, and safety concerns attributed to potential adventitious agents present in serum and serum-derived proteins, regulatory agencies have encouraged replacement of these components. Recombinant albumin and transferrin can successfully replace serum-derived proteins these applications.

Read Here
Slide 2
Featured Review

Emergence of a Blood-Free rHSA

Blood-Free rHSA will add safety, consistency, and enhanced performance to your cell culturing processes.

Our new Featured Report explores the many benefits of albumin and the various challenges that serum-derived proteins can create. Recombinant human serum albumin (rHSA), and specifically InVitria’s Blood-Free rHSA, overcomes these challenges, enhances performance, and is preferred by regulatory agencies.

Read Here
Slide 2

Learn How Exbumin Became the First FDA- and EMA-Approved Excipient in the New Cell Culture Dish Article

Cell Culture Dish summarizes Merck's IPEC webinar detailing the first-hand account of the complex process of regulatory agency drug product filing. The journey focuses on Merck's Ebola vaccine ERVEBO® and how it came to use Exbumin as an excipient.

Read Article Here
Slide 2

NEW White Paper

Learn how recombinant transferrin enhances transient transfection and functional titer in viral vector production.

Click To View and Download
Home page banner image

Performance. Defined.

The global leader in the production of blood-free components, supplements, and media to facilitate the approval of life changing medicines.

Connect with Us to Learn More
previous arrow
next arrow

InVitria Serum Free Cell Culture Media Components & Optimization

Product Applications

InVitria’s portfolio of chemically defined blood-free products enables development and production of novel therapeutics without use of any blood-derived components.

Click on the application of interest to find out how our products set the new standards in biologics manufacturing.

Learn More

Product Types

InVitria offers a suite of recombinant protein products, each of which is completely free of animal or human components and produced in a scalable, non-mammalian recombinant expression system at an ISO9001:2015 certified facility in Kansas, USA.

Learn More

Custom Media Formulation

InVitria is the leading brand of custom media formulations for gene therapy, cell therapy, vaccine & antibody production, and related culturing applications. Contact us to discuss your cell culture needs. Let us do the heavy lifting!

Learn More

  • Blood-Free & Chemically Defined
  • High Performance
  • Reliable Supply Chain
  • Faster Time to Market

2021 Product Catalog

Download InVitria’s Product Catalog to learn more about our:

  • Recombinant Proteins
  • Cell Culture Supplements
  • Blood-Free Cell Culture Media

Download PDF

Search Our Knowledge Base

Select the cell line or an application of interest and discover more information relevant to your work.

or just browse

Adherent HEK293t Cells Cultured in Pall’s iCELLis® Bioreactor with OptiPEAK HEK293t Blood-Free Chemically Defined Media Exhibit Robust and Rapid Population Doubling Times

  • Decreased variability in cell culture media.
  • Accelerated gene therapy research.
  • Improved scalability & increased speed of gene therapy manufacturing.
  • Reduced cost in time and resources for manufacturing.
Learn More